BREXIT will bring some uncertainty to pharma operations in Europe. New product types such as biologics and personalised medicine will increase pressure to develop innovative solutions for factory building and engineering solutions.
The Executive Forum will highlight these limitations and also look at how other branches shape innovation. Our programme features top speakers from Astra Zeneca, GE Healthcare, Pfizer, Wuxi Biologics, University St. Gallen, and the former Ministry of Health and Economy Ireland.
Top keynote speakers from big pharma manufacturers Sanofi, Takeda/Shire, Gilead, and Johnson & Johnson will give insight into their approaches to innovation and how to form a successful next decade for their operations. The FDA will give an update on important regulation.
The 2019 ISPE Europe Annual Conference will focus on four core areas that continue to drive, challenge, and shape pharma manufacturing.
Focus on innovation in facilities and production
Practical implementation of industry 4.0 concepts into pharmaceutical operations
Current case studies and presentations that demonstrates ways of working that relate to how industry operates and innovates to meet current and proposed regulatory requirements
Emphasise how project managers and engineers, in an ever-changing world, can adapt their practices to ensure they continue to deliver consistent successful, modern engineering, and project delivery
Professionals at all levels of the industry from young professionals to the most senior executives, Communities of Practice, special interest groups, pharmaceutical industry equipment and services suppliers, and regulatory professionals.